10-K/A XBRL

FORM 10-K/A

Company: Anika Therapeutics, Inc.
Filed: April 26, 2021
Period of Report: December 31, 2020
Accession Number: 0001171843-21-002766

View Document ↗ View on SEC.gov ↗